EXS2:F:F-iShares TecDAX UCITS ETF (DE) (EUR)

ETF | Others |

Last Closing

USD 29.315

Change

0.00 (0.00)%

Market Cap

USD 0.71B

Volume

1.97K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-02 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

+0.16 (+0.60%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.36 (+0.70%)

USD 117.56B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.38 (+0.68%)

USD 97.02B
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 89.53B
EUNL:F iShares Core MSCI World UCITS ..

+0.25 (+0.26%)

USD 72.04B
FRCJ:F UBS MSCI Japan Socially Respon..

+0.17 (+0.74%)

USD 71.25B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

USD 58.22B
SXRZ:F iShares VII PLC - iShares Nikk..

+2.90 (+1.25%)

USD 56.96B
VUAA:F Vanguard S&P 500 UCITS Acc

-0.04 (-0.04%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

-0.13 (-0.13%)

USD 51.63B

ETFs Containing EXS2:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -1.25% 28% F 48% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -1.25% 26% F 42% F
Trailing 12 Months  
Capital Gain 2.93% 38% F 55% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.93% 35% F 48% F
Trailing 5 Years  
Capital Gain 8.96% 41% F 51% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.96% 41% F 38% F
Average Annual (5 Year Horizon)  
Capital Gain 3.21% 54% F 57% F
Dividend Return 3.21% 52% F 51% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 14.64% 42% F 74% C
Risk Adjusted Return 21.91% 47% F 53% F
Market Capitalization 0.71B 68% D+ 54% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.